← Leaderboards

Cristian Apetrei

University Of Pittsburgh At Pittsburgh

Google Scholar ↗PubMed ↗ORCID ↗

$24,938,676

Attributed

$29,808,316

Total exposure

68

Grants

53

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3M · FY2005–25

$5M$3.8M$2.5M$1.3M$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$29,808,316 · 68

By mechanism

R01$21,665,015 · 7

P51$4,479,936 · 53

P01$2,267,403 · 2

P20$1,023,489 · 5

R56$372,473 · 1

Top collaborators

Most similar at University Of Pittsburgh At Pittsburgh

Same institution · by research overlap

Andrea Gambotto$6,859,177

Others in their field

Top investigators on “Infection”

Wafaa M. El-Sadr · Columbia University Health Sciences$965,939,185
Lawrence Corey · Fred Hutchinson Cancer Center$789,608,171
Judith S. Currier · University Of California Los Angeles$511,038,212
Margaret Juliana McElrath · Fred Hutchinson Cancer Center$463,711,983
Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
Joseph J. Eron · Univ Of North Carolina Chapel Hill$415,229,497

Research focus

InfectionVirusCd4 Positive T LymphocytesMacaca MulattaPathogenesisViralUnited States National Institutes Of HealthChronicFundingImmuneDisease ProgressionResourcesInstitutionComputer Retrieval Of Information On Scientific Projects DatabaseAcquired Immunodeficiency SyndromeResearch PersonnelGrantSourcePlasmaIntestinesCellsT-Cell DepletionHiv-1Design

Grant awards (104)

Impact of metabolic programing of T cells from the GI tract and related tissues on HIV reservoir seeding, maintenance and reactivation$775,683

R01 · FY2025 · DK · contact PI

Assessing the Role of GI Tract Dysfunction to HIV/SIV Disease Progression$666,186

R01 · FY2025 · DK

Microneedle patch delivery of replication-inducible monkeypox vaccine$547,988

R01 · FY2025 · AI

Impact of metabolic programing of T cells from the GI tract and related tissues on HIV reservoir seeding, maintenance and reactivation$744,929

R01 · FY2024 · DK · contact PI

Assessing the Role of GI Tract Dysfunction to HIV/SIV Disease Progression$665,909

R01 · FY2024 · DK

Impact of metabolic programing of T cells from the GI tract and related tissues on HIV reservoir seeding, maintenance and reactivation$776,241

R01 · FY2022 · DK · contact PI

New Strategy to Improve Gastrointestinal Health in SIV/HIV$762,838

R01 · FY2022 · DK · contact PI

Impact of metabolic programing of T cells from the GI tract and related tissues on HIV reservoir seeding, maintenance and reactivation$794,896

R01 · FY2021 · DK · contact PI

New Strategy to Improve Gastrointestinal Health in SIV/HIV$762,838

R01 · FY2021 · DK · contact PI

Assessing the Role of GI Tract Damage to HIV/SIV Disease Progression$707,610

R01 · FY2021 · DK

New Strategy to Improve Gastrointestinal Health in SIV/HIV$690,235

R01 · FY2021 · DK · contact PI

New Strategy to Improve Gastrointestinal Health in SIV/HIV$776,963

R01 · FY2020 · DK · contact PI

Assessing the Role of GI Tract Damage to HIV/SIV Disease Progression$734,500

R01 · FY2020 · DK

Impact of a SARS-CoV-2 vaccine on gut integrity, immune activation and efficacy of ART$705,280

R01 · FY2020 · DK · contact PI

Animal Model for Testing SIV Latency Reversal Strategies$734,167

R01 · FY2019 · AI · contact PI

Assessing the Role of GI Tract Damage to HIV/SIV Disease Progression$732,881

R01 · FY2019 · DK

New Strategy to Improve Gastrointestinal Health in SIV/HIV$696,051

R01 · FY2019 · DK · contact PI

Animal Model for Testing SIV Latency Reversal Strategies$847,031

R01 · FY2018 · AI · contact PI

Assessing the Role of GI Tract Damage to HIV/SIV Disease Progression$715,521

R01 · FY2018 · DK

New Strategy to Improve Gastrointestinal Health in SIV/HIV$704,551

R01 · FY2018 · DK · contact PI

Assessing the Role of GI Tract Damage to HIV/SIV Disease Progression$764,703

R01 · FY2017 · DK

Animal Model for Testing SIV Latency Reversal Strategies$725,089

R01 · FY2017 · AI · contact PI

Animal Model for Testing SIV Latency Reversal Strategies$718,966

R01 · FY2016 · AI · contact PI

Animal Model for Testing SIV Latency Reversal Strategies$390,499

R01 · FY2015 · AI · contact PI

Mucosal transmission and pathogenicity of novel SIVsmm virus strains$398,122

P01 · FY2014 · AI · contact PI

Mucosal transmission and pathogenicity of novel SIVsmm virus strains$458,714

P01 · FY2013 · AI · contact PI

Early Events and Determinants of Oral SIV Transmission in Infant Nonhuman Primate$372,473

R56 · FY2013 · DE · contact PI

Mucosal transmission and pathogenicity of novel SIVsmm virus strains$475,244

P01 · FY2012 · AI · contact PI

Mucosal transmission and pathogenicity of novel SIVsmm virus strains$473,114

P01 · FY2011 · AI · contact PI

Animal Model for SIV Infection Control$757,320

R01 · FY2010 · RR · contact PI

Mucosal transmission and pathogenicity of novel SIVsmm virus strains$462,209

P01 · FY2010 · AI · contact PI

Animal Model for SIV Infection Control$373,679

R01 · FY2010 · RR · contact PI

SIMIAN IMMUNODEFICIENCY VIRUSES EXPOSURE IN HUMANS IN RURAL CAMEROON$61,801

P51 · FY2010 · RR · contact PI

PATHOGENESIS OF NEW SIVSMM LINEAGES IN RHESUS MACAQUES$61,801

P51 · FY2010 · RR · contact PI

Animal Model for SIV Infection Control$756,918

R01 · FY2009 · RR · contact PI

Pathogenesis of New SIVsm Lineages in Rhesus Macaques$357,378

R01 · FY2009 · AI · contact PI

Pathogenesis of New SIVsm Lineages in Rhesus Macaques$332,879

R01 · FY2009 · AI · contact PI

CD20 DEPLETION IN SIVSMM-INFECTED RHESUS MACAQUES$62,691

P51 · FY2009 · RR · contact PI

DEVELOPMENT OF INFECTIOUS CLONES OF SIVSM STRAINS BELONGING TO DIFFERENT CLADES$59,930

P51 · FY2009 · RR · contact PI

SIMIAN IMMUNODEFICIENCY VIRUSES EXPOSURE IN HUMANS IN RURAL CAMEROON$59,930

P51 · FY2009 · RR · contact PI

PATHOGEN DETECTION AND QUANTIFICATION CORE$59,930

P51 · FY2009 · RR · contact PI

PATHOGENESIS OF NEW SIVSMM LINEAGES IN RHESUS MACAQUES$57,259

P51 · FY2009 · RR · contact PI

LSU VETERINARY COBRE: PATHOGENESIS OF NEW SIVSM LINEAGES IN RHESUS MACAQUES$49,732

P20 · FY2009 · RR · contact PI

Pathogenesis of New SIVsm Lineages in Rhesus Macaques$654,895

R01 · FY2008 · AI · contact PI

PATHOGENESIS OF NEW SIVSMM LINEAGES IN RHESUS MACAQUES$65,282

P51 · FY2008 · RR · contact PI

CHARACTERIZATION OF A NEW SIVAGI FROM AGILE MANGABEY (CERCOCEBUS AGILIS)$64,195

P51 · FY2008 · RR · contact PI

SIMIAN IMMUNODEFICIENCY VIRUSES EXPOSURE IN HUMANS IN RURAL CAMEROON$64,195

P51 · FY2008 · RR · contact PI

SIVRCM INFECTION IN PIG-TAILED MACAQUES$64,195

P51 · FY2008 · RR · contact PI

DEVELOPMENT OF INFECTIOUS CLONES OF SIVSM STRAINS BELONGING TO DIFFERENT CLADES$64,195

P51 · FY2008 · RR · contact PI

SIVSMM SUBTYPES INDUCE IMMUNOLOGIC AND VIROLOGIC CHANGES IN SOOTY MANGABEYS$64,195

P51 · FY2008 · RR · contact PI

SEQUENCE DIVERSITY AMONG CHIMPANZEE SIMIAN IMMUNODEFICIENCY VIRUS (SIVCPZ)$64,195

P51 · FY2008 · RR · contact PI

CD20 DEPLETION IN SIVSMM-INFECTED RHESUS MACAQUES$64,195

P51 · FY2008 · RR · contact PI

ANIMAL MODEL FOR ELITE CONTROLLED SIV INFECTION MACAQUES$64,195

P51 · FY2008 · RR · contact PI

PATHOGEN DETECTION AND QUANTIFICATION CORE$64,050

P51 · FY2008 · RR · contact PI

LSU VETERINARY COBRE: PATHOGENESIS OF NEW SIVSM LINEAGES IN RHESUS MACAQUES$46,649

P20 · FY2008 · RR · contact PI

Pathogenesis of New SIVsm Lineages in Rhesus Macaques$675,639

R01 · FY2007 · AI · contact PI

CD20 DEPLETION IN SIVSMM-INFECTED RHESUS MACAQUES$71,639

P51 · FY2007 · RR · contact PI

IMMUNOLOGIC AND VIROLOGIC CONSEQUENCES OF SIVSMM DIVERSITY IN SOOTY MANGABEYS$71,639

P51 · FY2007 · RR · contact PI

SEQUENCE DIVERSITY AMONG CHIMPANZEE SIMIAN IMMUNODEFICIENCY VIRUS (SIVCPZ)$71,639

P51 · FY2007 · RR · contact PI

CELLULAR IMMUNE RESPONSES IN NATURALLY SIV-INFECTED SOOTY MANGABEYS$71,639

P51 · FY2007 · RR · contact PI

INFECTIOUS CLONES OF SIVSM STRAINS BELONGING TO DIFFERENT CLADES$71,639

P51 · FY2007 · RR · contact PI

SIVRCM INFECTION IN PIG-TAILED MACAQUES$71,639

P51 · FY2007 · RR · contact PI

SIVSM ISOLATES OF VARIED CLADES SHOW RESTRICTIVE IN VITRO GROWTH PATTERNS$71,639

P51 · FY2007 · RR · contact PI

SIMIAN IMMUNODEFICIENCY VIRUSES EXPOSURE IN HUMANS IN RURAL CAMEROON$71,639

P51 · FY2007 · RR · contact PI

VIRAL DIAGNOSTIC CORE$71,638

P51 · FY2007 · RR · contact PI

PATHOGENESIS OF NEW SIVSMM LINEAGES INRHESUS MACAQUES$71,638

P51 · FY2007 · RR · contact PI

CHARACTERIZATION OF A NEW SIV FROM AGILE MANGABEY (CERCOCEBUS AGILIS)$71,638

P51 · FY2007 · RR · contact PI

LSU VETERINARY COBRE: PATHOGENESIS OF NEW SIVSM LINEAGES IN RHESUS MACAQUES$67,520

P20 · FY2007 · RR · contact PI

IDENTIFICATION OF HEPATITIS B VIRUS SUBGENOTYPE A3 IN RURAL GABON$30,392

P51 · FY2007 · RR · contact PI

Pathogenesis of New SIVsm Lineages in Rhesus Macaques$614,752

R01 · FY2006 · AI · contact PI

LSU VETERINARY COBRE: PATHOGENESIS OF NEW SIVSM LINEAGES IN RHESUS MACAQUES$285,712

P20 · FY2006 · RR · contact PI

SIVSM DIVERSITY IN SOOTY MANGABYS AT THE YERKES NPRC$65,435

P51 · FY2006 · RR · contact PI

DEVELOPMENT OF INFECTIOUS CLONES OF SIVSM STRAINS BELONGING TO DIFFERENT CLADES$65,435

P51 · FY2006 · RR · contact PI

SIVRCM INFECTION IN PIG-TAILED MACAQUES$65,435

P51 · FY2006 · RR · contact PI

KURU EXPERIMENTS TRIGGERED THE EMERGENCE OF PATHOGENIC SIVMAC$65,435

P51 · FY2006 · RR · contact PI

SIVSM ISOLATES OF VARIED CLADES SHOW RESTRICTIVE IN VITRO GROWTH PATTERNS$65,435

P51 · FY2006 · RR · contact PI

PRIMARY SIVMND-2 INFECTION IN MANDRILLS (MANDRILLUS SPHINX)$65,435

P51 · FY2006 · RR · contact PI

SIMIAN IMMUNODEFICIENCY VIRUSES EXPOSURE IN HUMANS IN RURAL CAMEROON$65,435

P51 · FY2006 · RR · contact PI

SIVSM DIVERSITY IN PRIMATE CENTERS IN THE UNITED STATES AND ITS IMPLICATIONS$65,435

P51 · FY2006 · RR · contact PI

CHARACTERIZATION OF A NEW SIV FROM AGILE MANGABEY (CERCOCEBUS AGILIS)$65,435

P51 · FY2006 · RR · contact PI

POTENTIAL FOR TRANSMISSION OF BLOOD BORNE PATHOGENS BY SYRINGES IN CAMEROON$65,435

P51 · FY2006 · RR · contact PI

VIRAL DIAGNOSTIC CORE$65,435

P51 · FY2006 · RR · contact PI

COMPARATIVE PATHOGENESIS OF SIVSM VIRUSES OF DIFFERENT GENETIC LINEAGES$28,846

P51 · FY2006 · RR · contact PI

VIRAL DIAGNOSTIC CORE$899,500

P51 · FY2005 · RR

LSU VETERINARY COBRE: PATHOGENESIS OF NEW SIVSM LINEAGES IN RHESUS MACAQUES$251,584

P20 · FY2005 · RR

SIVSM DIVERSITY IN PRIMATE CENTERS IN THE UNITED STATES AND ITS IMPLICATIONS$54,500

P51 · FY2005 · RR

AIDS IN A BLACK MANGABEY FOLLOWING CROSS-SPECIES TRANSMISSION OF SIVSM$54,500

P51 · FY2005 · RR

CHARACTERIZATION OF A NEW SIV FROM AGILE MANGABEY (CERCOCEBUS AGILIS)$54,500

P51 · FY2005 · RR

CHARACTERIZATION OF NEW SIVSM STRAINS FROM SIERRA LEONE$54,500

P51 · FY2005 · RR

POTENTIAL FOR TRANSMISSION OF BLOOD BORNE PATHOGENS BY SYRINGES IN CAMEROON$54,500

P51 · FY2005 · RR

COMPARATIVE PATHOGENESIS OF SIVSM VIRUSES OF DIFFERENT GENETIC LINEAGES$52,113

P51 · FY2005 · RR

NEW MEASLES VACCINE STRATEGY USING VSV VECTORS$322,292

P20 · FY2004 · RR

CAMEROON: BLOOD BORNE PATHOGENS TRANSMISSION BY NEEDLES$47,161

P51 · FY2004 · RR

VIRAL DIAGNOSTIC CORE$47,161

P51 · FY2004 · RR

SIVSM DIVERSITY IN PRIMATE CENTERS IN THE UNITED STATES AND ITS IMPLICATIONS$47,161

P51 · FY2004 · RR

CHARACTERIZATION OF A NEW SIV FROM AGILE MANGABEY$47,161

P51 · FY2004 · RR

NEW SIVSM STRAINS FROM SIERRA LEONE BUSH MEAT SAMPLES$47,161

P51 · FY2004 · RR

CROSS-SPECIES TRANSMISSION OF SIVSM: BLACK MANGABEY AIDS$47,161

P51 · FY2004 · RR

CHARACTERIZATION OF NEWLY DERIVED HIV-1 GROUP N STRAINS$47,161

P51 · FY2004 · RR

COMPARATIVE PATHOGENESIS OF SIVSM VIRUSES$46,173

P51 · FY2004 · RR

VIROLOGICAL AND GENETIC CHARACTERIZATION OF NEWLY DERIVED HIV-1 GROUP N STRAINS$61,560

P51 · FY2003 · RR

EXPERIMENTAL STUDIES ON SIVMND-1 PRIMARY INFECTION IN MANDRILLS$61,560

P51 · FY2003 · RR

RELIABILITY OF RAPID DIAGNOSTIC TESTS FOR HIV VARIANT INFECTION$61,560

P51 · FY2003 · RR

A HIGH PREVALENCE OF HIV RECOMBINANT STRAINS IN GABON$61,560

P51 · FY2003 · RR